Pregnant women are routinely excluded from drug trials, leaving clinicians without dosing guidance. Discover how pharmacokinetic modeling and simulation are helping to change that.

All Press Coverage

FDA Blueprint Aims To Cut Regulatory Risk for Alternatives to Animal Testing

👁 Image

FDA Blueprint Aims To Cut Regulatory Risk for Alternatives to Animal Testing

How Bayesian Design Is Reshaping Clinical Development

👁 Image

How Bayesian Design Is Reshaping Clinical Development

Building Smarter Trials With Bayesian Statistics

👁 Image

Building Smarter Trials With Bayesian Statistics

All Press Coverage

Rethinking Trial Design With Bayesian Approaches

👁 Image

Rethinking Trial Design With Bayesian Approaches

FDA Support Drives Shift Toward Bayesian Trial Design

👁 Image

FDA Support Drives Shift Toward Bayesian Trial Design

Single Pivotal Trials Demand Stronger Data and Risk Strategies

👁 Image

Single Pivotal Trials Demand Stronger Data and Risk Strategies

Featured press release

All Press Release

Certara Announces CFO Transition

👁 Image

Certara Announces CFO TransitionPress Release

Certara Announces CFO Transition

RADNOR, Pa., June 17, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, announces that John Gallagher, Chief…

Latest press releases

All Press Release

Certara to Participate in Upcoming Investor Conferences

👁 Image

Certara to Participate in Upcoming Investor ConferencesPress Release

Certara to Participate in Upcoming Investor Conferences

Certara Reports First Quarter 2026 Financial Results

👁 Image

Certara Reports First Quarter 2026 Financial ResultsPress Release

Certara Reports First Quarter 2026 Financial Results

Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development

👁 Image

Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug DevelopmentPress Release

Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development

Recent Announcements

All Announcement

Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-risk Investment and Accelerate Development

👁 Image

Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-risk Investment and Accelerate DevelopmentAnnouncement

Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-risk Investment and Accelerate Development

Chemaxon retires JChem for Office Lite

👁 Image

Chemaxon retires JChem for Office LiteAnnouncement

Chemaxon retires JChem for Office Lite

Migrating to Chemaxon Java Libraries 26: What Changed and How to Adapt

👁 Image

Migrating to Chemaxon Java Libraries 26: What Changed and How to AdaptAnnouncement

Migrating to Chemaxon Java Libraries 26: What Changed and How to Adapt

Certara Integrates D360™ with Secondary Intelligence™ Software to Enhance Predicting Drug Safety Risk

👁 Image

Certara Integrates D360™ with Secondary Intelligence™ Software to Enhance Predicting Drug Safety RiskAnnouncement

Certara Integrates D360™ with Secondary Intelligence™ Software to Enhance Predicting Drug Safety Risk

Certara Reappointed for a European Medicines Agency Contract, Expanding Opportunities to Shape the Future of Real-World Evidence for Regulatory Decision-Making

👁 Image

Certara Reappointed for a European Medicines Agency Contract, Expanding Opportunities to Shape the Future of Real-World Evidence for Regulatory Decision-MakingAnnouncement

Certara Reappointed for a European Medicines Agency Contract, Expanding Opportunities to Shape the Future of Real-World Evidence for Regulatory Decision-Making

Modernizing the Academic Program and Retiring Chemicalize

👁 Image

Modernizing the Academic Program and Retiring ChemicalizeAnnouncement

Modernizing the Academic Program and Retiring Chemicalize

All news

Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-risk Investment and Accelerate Development

Announcement Certara Services Clinical Pharmacology Drug Development Homepage Latest Modeling and Simulation

Certara Integrates D360™ with Secondary Intelligence™ Software to Enhance Predicting Drug Safety Risk

Announcement Certara Products Drug Safety Homepage Latest

Certara Reappointed for a European Medicines Agency Contract, Expanding Opportunities to Shape the Future of Real-World Evidence for Regulatory Decision-Making

Announcement Certara Services Homepage Latest

The Case for Simulating Pregnancy

Press Coverage Certara Products - Simcyp Certara Services Modeling and Simulation Modeling and Simulation - PBPK

Modernizing the Academic Program and Retiring Chemicalize

Announcement Certara Products

Certara to Participate in Upcoming Investor Conferences

Press Release

Be the first to get the latest

Transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.

URL: https://www.certara.com/company/news/

News

Latest press coverage

Featured press coverage

Featured press release

Latest press releases

Recent Announcements

All news

Newsletter sign up

Quick links

Solutions

Contact